Atilotrelvir clinical trials
How each study uses atilotrelvir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the atilotrelvir studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2022 (3)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 1
Fujian Akeylink Biotechnology Co., Ltd. (6) · University of Oxford (1)
Often tested with
Tested in the same studies.
Ritonavir (1) · Nirmatrelvir and ritonavir drug combination (1) · Nitazoxanide (1) · Molnupiravir (1) · Nirmatrelvir (1) · Hydroxychloroquine (1) · Antibodies, Monoclonal (1) · Fluoxetine (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test atilotrelvir.
- Jan 2027Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)Phase 2 · University of Oxford
Studies
Open first, then newest update. How each study uses atilotrelvir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)RecruitingPhase 2University of OxfordNCT05041907Written as Atilotrelvir/ritonavir
- Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Liver FunctionCompletedPhase 1Fujian Akeylink Biotechnology Co., Ltd.NCT06106113Written as GST-HG171 Tablets
- Pharmacokinetics and Safety of GST-HG171 Tablets in Subjects With Impaired and Normal Renal FunctionStatus unknownNot applicableFujian Akeylink Biotechnology Co., Ltd.NCT06106126Written as GST-HG171 Tablets
- Drug-Drug Interaction Study of Itraconazole With GST-HG171/Ritonavir in Healthy ParticipantsCompletedPhase 1Fujian Akeylink Biotechnology Co., Ltd.NCT06087055Written as GST-HG171/Ritonavir
- Food Effects of GST-HG171 Tablets Combined With Ritonavir in Healthy Chinese ParticipantsActive, not recruitingPhase 1Fujian Akeylink Biotechnology Co., Ltd.NCT06084507Written as GST-HG171/ritonavir
- Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19CompletedPhase 2/3Fujian Akeylink Biotechnology Co., Ltd.NCT05656443Written as GST-HG171/Ritonavir
- Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on GST-HG171 TabletsCompletedPhase 1Fujian Akeylink Biotechnology Co., Ltd.NCT05668897Written as GST-HG171
Codes
What other systems call atilotrelvir · ClinicalTrials.gg INT016982
- UNII (FDA) JVV7PSN6VLATILOTRELVIRConfirmed FDA, Wikidata
- Wikidata Q131806354atilotrelvirConfirmed FDA, Wikidata
- NCI Thesaurus C203185AtilotrelvirOne source FDA
- DrugBank DB19439One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | JVV7PSN6VL | ATILOTRELVIR | Confirmed FDA, Wikidata |
| Wikidata | Q131806354 | atilotrelvir | Confirmed FDA, Wikidata |
| NCI Thesaurus | C203185 | Atilotrelvir | One source FDA |
| DrugBank | DB19439 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.